Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Genet Mol Res ; 16(1)2017 Mar 16.
Article in English | MEDLINE | ID: mdl-28362989

ABSTRACT

The objective of this study was to evaluate the effect of Moquiniastrum polymorphum ssp floccosum ethanolic extract (MPEE) on 1,2 dimethylhydrazine (DMH)-induced colorectal carcinogenesis in mice. Forty-two male Swiss mice (Mus musculus) were subdivided into six groups (N = 7/group): negative control, DMH, MPEE, pre-treatment, simultaneous, and post-treatment. Results showed that MPEE has antigenotoxic potential on the tested protocols pre- and silmultaneous treatment, and the percent damage reductions (%DRs) were 81.88 and 93.12%, respectively. The micronucleus test demonstrated that MPEE has great antimutagenic activity, with %DRs higher than 77.09 in the associated groups. The aberrant crypt focus assay demonstrated anticarcinogenic potential of MPEE as the associated groups showed %DRs that ranged from 62.13 to 95.14%. The study shows that MPEE is nontoxic and has chemopreventive and anticarcinogenic activity, thus it may prove to be a promising medicinal plant in view of its demonstrated properties.


Subject(s)
1,2-Dimethylhydrazine/toxicity , Aberrant Crypt Foci/drug therapy , Asteraceae/chemistry , Colorectal Neoplasms/drug therapy , Ethanol/administration & dosage , Aberrant Crypt Foci/prevention & control , Animals , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/pharmacology , Colorectal Neoplasms/chemically induced , Colorectal Neoplasms/prevention & control , DNA Damage/drug effects , Ethanol/pharmacology , Male , Mice , Micronucleus Tests , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/pharmacology , Xenograft Model Antitumor Assays
2.
Genet Mol Res ; 16(1)2017 Mar 22.
Article in English | MEDLINE | ID: mdl-28340269

ABSTRACT

Colorectal cancer is a global public health issue. Studies have pointed to the protective effect of probiotics on colorectal carcinogenesis. Activia® is a lacto probiotic product that is widely consumed all over the world and its beneficial properties are related, mainly, to the lineage of traditional yoghurt bacteria combined with a specific bacillus, DanRegularis, which gives the product a proven capacity to intestinal regulation in humans. The aim of this study was to evaluate the antigenotoxic, antimutagenic, and anticarcinogenic proprieties of the Activia product, in response to damage caused by 1,2-dimethylhydrazine (DMH) in Swiss mice. Activia does not have shown antigenotoxic activity. However, the percent of DNA damage reduction, evaluated by the antimutagenicity assay, ranged from 69.23 to 96.15% indicating effective chemopreventive action. Activia reduced up to 79.82% the induction of aberrant crypt foci by DMH. Facing the results, it is inferred that Activia facilitates the weight loss, prevents DNA damage and pre-cancerous lesions in the intestinal mucosa.


Subject(s)
Aberrant Crypt Foci/prevention & control , Anticarcinogenic Agents/pharmacology , Colorectal Neoplasms/prevention & control , DNA Damage , Probiotics/pharmacology , Yogurt/microbiology , 1,2-Dimethylhydrazine , Aberrant Crypt Foci/chemically induced , Aberrant Crypt Foci/genetics , Aberrant Crypt Foci/pathology , Animals , Colorectal Neoplasms/chemically induced , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Dietary Supplements , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Male , Mice
3.
Genet Mol Res ; 15(4)2016 Oct 24.
Article in English | MEDLINE | ID: mdl-27813611

ABSTRACT

Moquiniastrum polymorphum subsp floccosum (Cabrera) G. Sancho is used in traditional Brazilian medicine to treat inflammation and infection, which is supported by scientific data. However, only one study has been conducted on the mutagenic activity of the extract, which has important safety implications. This study evaluated the mutagenic/antimutagenic activity of M. polymorphum ethanolic extract (MPEE) in Allium cepa meristematic cells. Commercial A. cepa seeds were cultured for 120 h. Treatments were performed for 48 h with MPEE (10 mg/mL), methyl methanesulfonate (MMS; 0.01 mg/mL), or in combination (MPEE + MMS). All of the experiments were performed in triplicate. A total of 15,000 cells per treatment were analyzed for chromosomal aberrations and the mitotic index. The results showed that MPEE was not mutagenic. In combination with MMS, MPEE decreased the number of damaged cells and the mitotic index. Interestingly, the most pronounced effect was observed post-treatment when the mitotic index also decreased, suggesting that MPEE may affect the cell cycle. MPEE exhibited antimutagenic activity, and may induce cell cycle arrest in A. cepa.


Subject(s)
Antimutagenic Agents/pharmacology , Infections/genetics , Inflammation/genetics , Mutagenesis/drug effects , Plant Extracts/pharmacology , Antimutagenic Agents/chemistry , Asteraceae/chemistry , Asteraceae/genetics , Brazil , Cell Cycle/drug effects , Chromosome Aberrations/drug effects , Infections/drug therapy , Inflammation/drug therapy , Medicine, Traditional , Mitotic Index , Onions/drug effects , Plant Extracts/chemistry
4.
Genet Mol Res ; 15(3)2016 Sep 02.
Article in English | MEDLINE | ID: mdl-27706690

ABSTRACT

The current study aims to evaluate the macroscopic and histological effects of autologous mesenchymal stem cells (MSC) and platelet-rich plasma on knee articular cartilage regeneration in an experimental model of osteoarthritis. Twenty-four rabbits were randomly divided into four groups: control group, platelet-rich plasma group, autologous MSC undifferentiated group, and autologous MSC differentiated into chondrocyte group. Collagenase solution was used to induce osteoarthritis, and treatments were applied to each group at 6 weeks following osteoarthritis induction. After 60 days of therapy, the animals were euthanized and the articular surfaces were subjected to macroscopic and histological evaluations. The adipogenic, chondrogenic, and osteogenic differentiation potentials of MSCs were evaluated. Macroscopic and histological examinations revealed improved tissue repair in the MSC-treated groups. However, no difference was found between MSC-differentiated and undifferentiated chondrocytes. We found that MSCs derived from adipose tissue and platelet-rich plasma were associated with beneficial effects in articular cartilage regeneration during experimental osteoarthritis.


Subject(s)
Chondrogenesis , Mesenchymal Stem Cell Transplantation , Osteoarthritis/therapy , Platelet Transfusion , Platelet-Rich Plasma/cytology , Regeneration/physiology , Adipocytes/cytology , Adipocytes/physiology , Animals , Cartilage, Articular/pathology , Cell Differentiation , Chondrocytes/cytology , Chondrocytes/physiology , Collagenases , Disease Models, Animal , Humans , Injections, Intra-Articular , Knee Joint/pathology , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/physiology , Osteoarthritis/chemically induced , Osteoarthritis/pathology , Osteoblasts/cytology , Osteoblasts/physiology , Rabbits , Transplantation, Autologous
5.
Genet Mol Res ; 15(2)2016 May 06.
Article in English | MEDLINE | ID: mdl-27173316

ABSTRACT

Acrocomia aculeata is a plant rich in antioxidant compounds. Studies suggest that this plant has anti-inflammatory, antidiabetic, and diuretic potential. We assessed the antigenotoxic, antimutagenic, immunomodulation, and apoptotic potentials of A. aculeata alone and in combination with an antitumor agent, cyclophosphamide. Swiss male mice (N = 140) were used. The animals were divided into 14 experimental groups as follows: a negative group, a positive group (100 mg/kg cyclophosphamide), groups that only received the oil extracted from the almond (AO) and from the pulp (PO) of A. aculeata at doses of 3, 15, and 30 mg/kg, and the associated treatment groups (oils combined with cyclophosphamide) involving pretreatment, simultaneous, and post-treatment protocols. Data suggest that both oils were chemopreventive at all doses, based on the tested protocols. The highest damage reduction percentages, observed for AO and PO were 88.19 and 90.03%, respectively, for the comet assay and 69.73 and 70.93%, respectively, for the micronucleus assay. Both AO and PO demonstrated immunomodulatory activity. The oils reduced the capacity of cyclophosphamide to trigger apoptosis in the liver, spleen, and kidney cells. These results suggest that A. aculeate AO and PO can be classified as a functional food and also enrich other functional foods and nutraceuticals with chemopreventive features. However, they are not appropriate sources for chemotherapeutic adjuvants, in particular for those used in combination with cyclophosphamide.


Subject(s)
Antineoplastic Agents/toxicity , Antioxidants/pharmacology , Arecaceae/chemistry , Cyclophosphamide/toxicity , DNA Damage , Plant Extracts/pharmacology , Animals , Apoptosis , Kidney/drug effects , Liver/drug effects , Male , Mice , Spleen/drug effects
6.
Genet Mol Res ; 14(1): 1679-91, 2015 Mar 06.
Article in English | MEDLINE | ID: mdl-25867310

ABSTRACT

Resistant starch is formed from starch and its degradation products and is not digested or absorbed in the intestine; thus, it is characterized as a fiber. Because fiber intake is associated with the prevention of DNA damage and cancer, the potential antigenotoxic, antimutagenic, and anticarcinogenic capabilities of resistant starch from green banana flour were evaluated. Animals were treated with 1,2-dimethylhydrazine and their diet was supplemented with 10% green banana flour according to the following resistant starch protocols: pretreatment, simultaneous treatment, post-treatment, and pre + continuous treatment. The results demonstrated that resistant starch is not genotoxic, mutagenic, or carcinogenic. The results suggest that resistant starch acts through desmutagenesis and bio-antimutagenesis, as well as by reducing aberrant crypt foci, thereby improving disease prognosis. These findings imply that green banana flour has therapeutic properties that should be explored for human dietary applications.


Subject(s)
Carcinogenesis/drug effects , DNA Damage , Dietary Fiber/administration & dosage , Functional Food , Starch/chemistry , Aberrant Crypt Foci , Animals , Colorectal Neoplasms/prevention & control , Comet Assay , Dimethylhydrazines/adverse effects , Disease Models, Animal , Flour , Food Handling , Male , Mice , Micronucleus Tests , Musa
7.
Genet Mol Res ; 14(1): 2422-35, 2015 Mar 27.
Article in English | MEDLINE | ID: mdl-25867388

ABSTRACT

The present study investigated the effects of restricting protein and calories and supplementation of inulin, a fiber comprising a linear type of polydisperse carbohydrates composed primarily of fructil-fructose bonds (ß-(2→1), on the deficiency statuses of animals in which genomic lesion development and colorectal carcinogenesis had been induced. This experiment involved adult male Swiss mice (N = 11/group). The experimental groups were as follows: Negative Control (vehicle), Positive Control, 1,2-dimethylhydrazine (DMH), Inulin, and Associate. DMH, which promoted colorectal cancer, was administered intraperitoneally in 4 20-mg/kg body weight (bw) doses during a 2-week period; inulin was administered orally at a daily dose of 50 mg/kg bw. Each group was bifurcated; half of each group was fed a normal protein diet and the other half was fed a low-protein diet. The results indicated that a correlation existed between malnutrition and an increased frequency of genomic lesions but that malnutrition did not predispose animals to colorectal cancer development. Inulin exhibited genotoxic activity, which requires further investigation, and low anti-genotoxic activity. Moreover, inulin reduced the levels of intestinal carcinogenesis biomarkers in both malnourished and healthy animals. These data suggest that inulin holds therapeutic potential and is a strong candidate for inclusion among the functional foods used for cancer prevention in both properly nourished and malnourished individuals.


Subject(s)
Colorectal Neoplasms/etiology , DNA Damage , Diet, Protein-Restricted , Dietary Supplements , Inulin/administration & dosage , Animals , Caloric Restriction , Carcinogenesis , Colorectal Neoplasms/genetics , Male , Malnutrition/complications , Malnutrition/etiology , Mice
8.
Genet Mol Res ; 14(1): 834-49, 2015 Feb 02.
Article in English | MEDLINE | ID: mdl-25730023

ABSTRACT

The compounds 6-dimethylaminopurine (6-DMAP) and cyclohexamide (CHX) are currently used to stimulate the development of embryos produced by nuclear transfer in the production of cloned mammals with a great deal success. This study investigated the effects of 6-DMAP and CHX in vivo using biological assays to evaluate reproductive performance in females, teratogenesis, and mutagenesis. The results of this study demonstrated that the activating agents of oocyte cytoplasm, 6-DMAP and CHX, altered the reproductive performance of the experimental animals, as well as increased the rate malformations. In addition to these adverse effects, the administration of these compounds in pregnant females resulted in genotoxic and mutagenic toxicity, as determined by comet and micronucleus assays carried out in peripheral blood samples, respectively. Based on these findings and that alterations in DNA are important, morpho-functional teratogenesis and diminished embryonic viability, suggesting that 6-DMAP and CHX, which are utilized during the cloning of mammals, are responsible for the fact that embryos produced by nuclear transfer show low viability after implantation in utero or after birth because of congenital malformations and/or alterations in their DNA.


Subject(s)
Adenine/analogs & derivatives , Cloning, Organism , Cycloheximide/adverse effects , Mutagens/adverse effects , Reproduction/drug effects , Adenine/adverse effects , Animals , Embryo Transfer , Female , Mice , Pregnancy , Reproduction/genetics , Teratogenesis/drug effects
9.
Genet Mol Res ; 13(4): 9523-32, 2014 Nov 12.
Article in English | MEDLINE | ID: mdl-25501162

ABSTRACT

In this study, we evaluated the mutagenic and antimutagenic activities of carrageenan, a sulfated polysaccharide, and described its mode of action by using an Allium cepa assay. The results indicate that carrageenan is not mutagenic, rather it has significant chemopreventive potential that is mediated by both demutagenic and bio-antimutagenic activities. This compound can adsorb agents that are toxic to DNA and inactivate them. Additionally, carrageenan can modulate enzymes of the DNA repair system. The percentage of damage reduction ranged from 62.54 to 96.66%, reflecting the compound's high efficiency in preventing the type of mutagenic damage that may be associated with tumor development. Based on these findings and information available in the literature, we conclude that carrageenan is an important fiber that should be considered as a possible base for functional foods and/or diets with potential anticancer activity.


Subject(s)
Antimutagenic Agents/pharmacology , Carrageenan/pharmacology , Meristem/cytology , Onions/cytology , Cells, Cultured , Chromosome Aberrations , Chromosomes, Plant/genetics , Meristem/drug effects , Mitotic Index , Onions/drug effects
10.
Genet Mol Res ; 13(4): 9986-96, 2014 Nov 28.
Article in English | MEDLINE | ID: mdl-25501210

ABSTRACT

Polyphenolic compounds present in rosemary were found to have antioxidant properties, anticarcinogenic activity, and to increase the detoxification of pro-carcinogens. The aim of the study was to determine the effect the aqueous extract of rosemary (AER) on mutagenicity induced by methylmethane sulfonate in meristematic cells of Allium cepa, as well as to describe its mode of action. Anti-mutagenicity experiments were carried out with 3 different concentrations of AER, which alone showed no mutagenic effects. In antimutagenicity experiments, AER showed chemopreventive activity in cultured meristematic cells of A. cepa against exposure to methylmethane sulfonate. Additionally, post-treatment and simultaneous treatment using pre-incubation protocols were the most effective. Evaluation of different protocols and the percent reduction in DNA indicated bioantimutagenic as well desmutagenic modes of action for AER. AER may be chemopreventive and antimutagenic.


Subject(s)
Antimutagenic Agents/pharmacology , Meristem/cytology , Mutagens/pharmacology , Onions/cytology , Plant Extracts/pharmacology , Rosmarinus/chemistry , Water/chemistry , Chromosome Aberrations , DNA Damage , Methyl Methanesulfonate/pharmacology , Mitotic Index
11.
Genet Mol Res ; 13(3): 5606-16, 2014 Jul 25.
Article in English | MEDLINE | ID: mdl-25117318

ABSTRACT

We evaluated the effects of phenylalanine on reproductive performance and teratogenesis in mice, as well as we assessed its protective effect in mice treated with an acute dose of cyclophosphamide. Animals were divided into 6 experimental groups (females N = 15/group, males N = 5/group): G1, the negative control group, phosphate-buffered saline; G2, the positive control group, 35 mg cyclophosphamide/kg body weight (b.w.); G3 and G4 received phenylalanine at doses of 150 and 300 mg/ kg b.w., respectively; G5 and G6 received phenylalanine at doses of 150 and 300 mg/kg b.w. co-administered with cyclophosphamide at a dose of 35 mg/kg b.w., respectively. Pregnant mice received phenylalanine from 8-12 days of pregnancy and cyclophosphamide on the 10th day of treatment or the respective vehicles. In animals treated with cyclophosphamide, offspring fetal weight significantly decreased. The G5 and G6 groups, which received cyclophosphamide co-administered with phenylalanine, showed a smaller reduction in weight. Based on this analysis, the offspring from groups G2, G5, and G6 showed low weight due to pregnancy age. Moreover, at the doses used, phenylalanine did not interfere with embryo-fetal development. However, further studies are necessary to increase the understanding of the effects of phenylalanine on mouse reproductive performance and teratogenesis.


Subject(s)
Phenylalanine/adverse effects , Reproduction/drug effects , Teratogenesis/drug effects , Animals , Cyclophosphamide/adverse effects , Cyclophosphamide/pharmacology , Female , Male , Mice , Organ Size/drug effects , Phenylalanine/administration & dosage , Pregnancy , Pregnancy Outcome , Teratogens , Uterus
12.
Genet Mol Res ; 13(3): 4820-30, 2014 Jul 02.
Article in English | MEDLINE | ID: mdl-25062417

ABSTRACT

We evaluated the effects of glutamine on clastogenic and genotoxic damage prevention caused by the administration of cisplatin. Forty Swiss mice were divided into 8 experimental groups: G1 and G2, which were control groups; G3, G4, and G5, which were administered [2 doses of glutamine (orally)] separated by a 24-h period (150, 300, and 600 mg/kg, respectively), and a dose of phosphate-buffered saline by intraperitoneal injection; G6, G7, and G8, which were treated in the same manner as the previous groups, but received cisplatin rather than phosphate-buffered saline. The antimutagenicity groups showed damage reduction percentages of 79.05, 80.00, and 94.27% at the time point T1, 53.18, 67.05, and 64.74 at time point T2 for the 150, 300, and 600 mg/kg doses of glutamine, respectively. Antigenotoxic activity was evident for all 3 doses with damage reduction percentages of 115.05, 119.06, and 114.38 for the doses of glutamine of 150, 300, and 600 mg/ kg, respectively. These results suggest that further studies are needed to confirm the clastogenic activity of glutamine. However, our results may lead to rational strategies for supplementation of this antioxidant as an adjuvant in cancer treatment or for preventing genomic lesions.


Subject(s)
Antimutagenic Agents/pharmacology , Antioxidants/pharmacology , Cisplatin/pharmacology , Glutamine/pharmacology , Mutagens/pharmacology , Animals , Antineoplastic Agents/pharmacology , Cisplatin/antagonists & inhibitors , Comet Assay , DNA Damage , Injections, Intraperitoneal , Male , Mice , Micronucleus Tests
13.
Braz J Med Biol Res ; 47(4): 287-98, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24714812

ABSTRACT

The compounds 6-dimethylaminopurine and cycloheximide promote the successful production of cloned mammals and have been used in the development of embryos produced by somatic cell nuclear transfer. This study investigated the effects of 6-dimethylaminopurine and cycloheximide in vitro, using the thiazolyl blue tetrazolium bromide colorimetric assay to assess cytotoxicity, the trypan blue exclusion assay to assess cell viability, the comet assay to assess genotoxicity, and the micronucleus test with cytokinesis block to test mutagenicity. In addition, the comet assay and the micronucleus test were also performed on peripheral blood cells of 54 male Swiss mice, 35 g each, to assess the effects of the compounds in vivo. The results indicated that both 6-dimethylaminopurine and cycloheximide, at the concentrations and doses tested, were cytotoxic in vitro and genotoxic and mutagenic in vitro and in vivo, altered the nuclear division index in vitro, but did not diminish cell viability in vitro. Considering that alterations in DNA play important roles in mutagenesis, carcinogenesis, and morphofunctional teratogenesis and reduce embryonic viability, this study indicated that 6-dimethylaminopurine and cycloheximide utilized in the process of mammalian cloning may be responsible for the low embryo viability commonly seen in nuclear transfer after implantation in utero.


Subject(s)
Adenine/analogs & derivatives , Cloning, Organism/methods , Comet Assay , Cycloheximide/toxicity , Mutagens/toxicity , Adenine/toxicity , Animals , Cell Culture Techniques , Cell Survival/drug effects , Coloring Agents , Cytokinesis/drug effects , Hep G2 Cells/drug effects , Humans , Male , Mammals , Mice , Micronucleus Tests , Mutagenicity Tests , Nuclear Transfer Techniques , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Trypan Blue/pharmacology
14.
Braz. j. med. biol. res ; 47(4): 287-298, 8/4/2014. tab, graf
Article in English | LILACS | ID: lil-705764

ABSTRACT

The compounds 6-dimethylaminopurine and cycloheximide promote the successful production of cloned mammals and have been used in the development of embryos produced by somatic cell nuclear transfer. This study investigated the effects of 6-dimethylaminopurine and cycloheximide in vitro, using the thiazolyl blue tetrazolium bromide colorimetric assay to assess cytotoxicity, the trypan blue exclusion assay to assess cell viability, the comet assay to assess genotoxicity, and the micronucleus test with cytokinesis block to test mutagenicity. In addition, the comet assay and the micronucleus test were also performed on peripheral blood cells of 54 male Swiss mice, 35 g each, to assess the effects of the compounds in vivo. The results indicated that both 6-dimethylaminopurine and cycloheximide, at the concentrations and doses tested, were cytotoxic in vitro and genotoxic and mutagenic in vitro and in vivo, altered the nuclear division index in vitro, but did not diminish cell viability in vitro. Considering that alterations in DNA play important roles in mutagenesis, carcinogenesis, and morphofunctional teratogenesis and reduce embryonic viability, this study indicated that 6-dimethylaminopurine and cycloheximide utilized in the process of mammalian cloning may be responsible for the low embryo viability commonly seen in nuclear transfer after implantation in utero.


Subject(s)
Animals , Humans , Male , Mice , Adenine/analogs & derivatives , Comet Assay , Cloning, Organism/methods , Cycloheximide/toxicity , Mutagens/toxicity , Adenine/toxicity , Cell Culture Techniques , Coloring Agents , Cell Survival/drug effects , Cytokinesis/drug effects , /drug effects , Mammals , Micronucleus Tests , Mutagenicity Tests , Nuclear Transfer Techniques , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Trypan Blue/pharmacology
15.
Genet Mol Res ; 13(3): 4808-19, 2014 Feb 14.
Article in English | MEDLINE | ID: mdl-24615117

ABSTRACT

This study evaluated the mutagenicity and antimutagenicity of inulin in a chromosomal aberration assay in cultures of the meristematic cells of Allium cepa. The treatments evaluated were as follows: negative control--seed germination in distilled water; positive control--aqueous solution of methyl methanesulfonate (10 µg/mL MMS); mutagenicity--aqueous solutions of inulin (0.015, 0.15, and 1.50 µg/mL); and antimutagenicity--associations between MMS and the different inulin concentrations. The antimutagenicity protocols established were pre-treatment, simultaneous simple, simultaneous with pre-incubation, and post-treatment. The damage reduction percentage (DR%) was 43.56, 27.77, and 55.92% for the pre-treatment; -31.11, 18.51, and 7.03% for the simultaneous simple; 30.43, 19.12, and 21.11% for the simultaneous with pre-incubation; and 64.07, 42.96, and 53.70% for the post-treatment. The results indicated that the most effective treatment for inhibiting damages caused by MMS was the post-treatment, which was followed by the pre-treatment, suggesting activity by bioantimutagenesis and desmutagenesis. The Allium cepa assay was demonstrated to be a good screening test for this type of activity because it is easy to perform, has a low cost, and shows DR% that is comparable to that reported studies that evaluated the prevention of DNA damage in mammals by inulin.


Subject(s)
Antimutagenic Agents/pharmacology , Chromosome Aberrations/drug effects , Inulin/pharmacology , Methyl Methanesulfonate/pharmacology , Mutagens/pharmacology , Onions/drug effects , Cells, Cultured , DNA Damage , Meristem/cytology , Meristem/drug effects , Meristem/metabolism , Methyl Methanesulfonate/antagonists & inhibitors , Mitotic Index , Onions/cytology , Onions/metabolism
16.
Genet Mol Res ; 12(4): 6040-51, 2013 Dec 02.
Article in English | MEDLINE | ID: mdl-24338398

ABSTRACT

Cisplatin is an effective antineoplastic drug. However, it provokes considerable collateral effects, including genotoxic and clastogenic activity. It has been reported that a diet rich in glutamine can help inhibit such collateral effects. We evaluated this activity in 40 Swiss mice, distributed into eight experimental groups: G1 - Control group (PBS 0.1 mL/10 g body weight); G2 - cisplatin group (cisplatin 6 mg/kg intraperitoneally); G3, G4, G5 - glutamine groups (glutamine at 150, 300, and 600 mg/kg, respectively; orally); G6, G7, G8 - Pre-treatment groups (glutamine at 150, 300, and 600 mg/kg, respectively; orally and cisplatin 6 mg/kg intraperitonially). For the micronucleus assay, samples of blood were collected (before the first use of the drugs at T0, then 24 (T1) and 48 (T2) hours after the first administration). For the comet assay, blood samples were collected only at T2. The damage reduction percentages for the micronucleus assay were 90.0, 47.3, and 37.3% at T1 and 46.0, 38.6, and 34.7% at T2, for G6, G7, and G8 groups, respectively. For the comet assay, the damage reduction percentages were 113.0, 117.4, and 115.0% for G6, G7, and G8, respectively. We conclude that glutamine is able to prevent genotoxic and clastogenic damages caused by cisplatin.


Subject(s)
Antimutagenic Agents/pharmacology , Antineoplastic Agents/toxicity , Cisplatin/toxicity , DNA Damage , Glutamine/pharmacology , Animals , Antimutagenic Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Glutamine/therapeutic use , Leukocytes, Mononuclear/drug effects , Male , Mice , Micronucleus Tests , Mutagens/therapeutic use , Mutagens/toxicity
17.
Genet Mol Res ; 12(3): 2281-93, 2013 Jul 08.
Article in English | MEDLINE | ID: mdl-23884771

ABSTRACT

The incidence of colorectal cancer is growing worldwide. The characterization of compounds present in the human diet that can prevent the occurrence of colorectal tumors is vital. The oligosaccharide inulin is such a compound. The aim of this study was to evaluate the antigenotoxic, antimutagenic and anticarcinogenic effects of inulin in vivo. Our study is based on 3 assays that are widely used to evaluate chemoprevention (comet assay, micronucleus assay, and aberrant crypt focus assay) and tests 4 protocols of treatment with inulin (pre-treatment, simultaneous, post-treatment, and pre + continuous). Experiments were carried out in Swiss male mice of reproductive age. In order to induce DNA damage, we used the pro-carcinogenic agent 1,2-dimethylhydrazine. Inulin was administered orally at a concentration of 50 mg/kg body weight following the protocols mentioned above. Inulin was not administered to the control groups. Our data from the micronucleus assay reveal antimutagenic effects of inulin in all protocols. The percentage of inulin-induced damage reduction ranged from 47.25 to 141.75% across protocols. These data suggest that inulin could act through desmutagenic and bio-antimutagenic mechanisms. The anticarcinogenic activity (aberrant crypt focus assay) of inulin was observed in all protocols and the percentages of damage reduction ranged from 55.78 to 87.56% across protocols. Further tests, including human trials, will be necessary before this functional food can be proven to be effective in the prevention and treatment of colon cancer.


Subject(s)
Aberrant Crypt Foci/prevention & control , Antineoplastic Agents/therapeutic use , Inulin/therapeutic use , Administration, Oral , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacology , Chemoprevention , Colorectal Neoplasms/prevention & control , DNA Damage/drug effects , Inulin/administration & dosage , Inulin/pharmacology , Male , Mice , Micronuclei, Chromosome-Defective/drug effects
18.
Genet Mol Res ; 12(2): 1646-59, 2013 May 14.
Article in English | MEDLINE | ID: mdl-23765971

ABSTRACT

Previous studies in rodents treated with the pro-carcinogen 1,2-dimethylhydrazine suggested that the consumption of wheat bran protected against DNA damage in the colon and rectum. Based on this information, we evaluated wheat bran as a functional food in the prevention and treatment of colon cancer. We used the aberrant crypt focus assay to evaluate the anticarcinogenic potential of wheat bran (Triticum aestivum variety CD-104), the comet assay to evaluate its antigenotoxicity potential, and the micronucleus assay to evaluate its antimutagenic potential. The wheat bran gave good antimutagenic and anticarcinogenic responses; the DNA damage decreased from 90.30 to 26.37% and from 63.35 to 28.73%, respectively. However, the wheat bran did not significantly reduce genotoxicity. Further tests will be necessary, including tests in human beings, before this functional food can be recommended as an adjunct in the prevention and treatment of colon cancer.


Subject(s)
Anticarcinogenic Agents/pharmacology , Antimutagenic Agents/pharmacology , Dietary Fiber/pharmacology , Animals , Colon/drug effects , Colon/pathology , DNA Damage , Humans , Male , Mice , Micronucleus Tests , Organ Size/drug effects , Weight Gain/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...